PK
Therapeutic Areas
Allegra Medical Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Active Knee | Primary knee replacement | Commercial |
| MEGASYSTEM‑C | Modular tumour and femoral revision | Commercial |
| MP Reconstruction Prosthesis | Hip and knee revision | Commercial |
| Endo‑Model SL Knee Prosthesis | Knee replacement | Commercial |
| Sr‑HT‑Gahnite Coated Implants | Enhanced osteointegration for hip/knee implants | Regulatory submission (FDA) |
Leadership Team at Allegra Medical Technologies
JS
Jenny Swain
Chief Executive Officer
VW
Vincent Wang
Chief Financial Officer
EN
Ellen Newsom
Head of Technology and Innovation
SS
Sean St Clair Mulhearn
Non‑Executive Director
DN
Dr Nicholas Hartnell
Non‑Executive Director
JS
Justyn Stedwell
Company Secretary